Welcome Customer !

Membership

Help

Shanghai Weike Biotechnology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products

Shanghai Weike Biotechnology Co., Ltd

  • E-mail

    weike21@vip.163.com

  • Phone

    13501794748

  • Address

    Room 1103, Great Wall Building, No. 3000 Zhongshan North Road, Putuo District, Shanghai

Contact Now

Research grade rHu IL-12

NegotiableUpdate on 02/12
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin
Overview
As it relates to the standardization of GMP in the later stage, even in the early preclinical research stage, quality determined experimental materials are still important, which can easily and seamlessly transition to the clinical stage with strict GMP conditions. $r$n CellGenix amp; amp; #174; Research grade cytokines also have efficient performance, high quality and safety, and cost-effective design, and are widely used in various experimental designs and preclinical studies.
Product Details

Product Description: How to Translate

Research level, suitable for preclinical studies


Features:

  • High quality and safety;

  • No animal derived ingredients, derived from recombinant human cytokines expressed in E. coli;

  • Referring to FDA and strictly following GMP conditions for production, it can withstand audits from customers and regulatory authorities;

  • Strict quality control standards


Storage method:

  • Store at -20 ℃ to -80 ℃;

  • The diluent is stored at -20 ℃ to -80 ℃;

  • Avoid repeated freezing and thawing.


Application:

Research grade cytokines are used in preclinical research experiments.



  • Potency:Please refer to the specific COA activity potency for each batch.

  • dissolution:It is recommended to dissolve 200 μ l of sterile water (or PBS) to a concentration of 250 μ l/ml.

  • Dilution:Recommended for useCellGenix®Dilute serum-free culture medium. When diluting with PBS or basic culture medium, carrier protein (0.1% -1% albumin or 1% -10% appropriate serum) should be added. Dilution without following these recommendations may lead to a decrease in product activity.